Optimising the Duration of Adjuvant Trastuzumab in Early Breast Cancer in the UK

H M Earl; L Hiller; J Dunn; I Macpherson; D Rea; L Hughes-Davies; K McAdam; P Hall; J Mansi; D Wheatley; J E Abraham; C Caldas; S Gasson; E O'Riordan; M Wilcox; D Miles; D A Cameron; A Wardley

doi:10.1016/j.clon.2020.07.006

Optimising the Duration of Adjuvant Trastuzumab in Early Breast Cancer in the UK

H M Earl, L Hiller, J Dunn, I Macpherson, D Rea, L Hughes-Davies, K McAdam, P Hall, J Mansi, D Wheatley, J E Abraham, C Caldas, S Gasson, E O'Riordan, M Wilcox, D Miles, D A Cameron, A Wardley

Cancer Clinical Trials Unit

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	15-19
Journal	Clinical Oncology
Volume	33
Issue number	1
DOIs	https://doi.org/10.1016/j.clon.2020.07.006
Publication status	E-pub ahead of print - 25 Jul 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.clon.2020.07.006

Cite this

Earl, H. M., Hiller, L., Dunn, J., Macpherson, I., Rea, D., Hughes-Davies, L., McAdam, K., Hall, P., Mansi, J., Wheatley, D., Abraham, J. E., Caldas, C., Gasson, S., O'Riordan, E., Wilcox, M., Miles, D., Cameron, D. A., & Wardley, A. (2020). Optimising the Duration of Adjuvant Trastuzumab in Early Breast Cancer in the UK. Clinical Oncology, 33(1), 15-19. Advance online publication. https://doi.org/10.1016/j.clon.2020.07.006

@article{b1c419c2dda94238abeb22e619f9c4de,

title = "Optimising the Duration of Adjuvant Trastuzumab in Early Breast Cancer in the UK",

author = "Earl, {H M} and L Hiller and J Dunn and I Macpherson and D Rea and L Hughes-Davies and K McAdam and P Hall and J Mansi and D Wheatley and Abraham, {J E} and C Caldas and S Gasson and E O'Riordan and M Wilcox and D Miles and Cameron, {D A} and A Wardley",

year = "2020",

month = jul,

day = "25",

doi = "10.1016/j.clon.2020.07.006",

language = "English",

volume = "33",

pages = "15--19",

journal = "Clinical Oncology",

issn = "0936-6555",

publisher = "Elsevier",

number = "1",

}

Earl, HM, Hiller, L, Dunn, J, Macpherson, I, Rea, D, Hughes-Davies, L, McAdam, K, Hall, P, Mansi, J, Wheatley, D, Abraham, JE, Caldas, C, Gasson, S, O'Riordan, E, Wilcox, M, Miles, D, Cameron, DA & Wardley, A 2020, 'Optimising the Duration of Adjuvant Trastuzumab in Early Breast Cancer in the UK', Clinical Oncology, vol. 33, no. 1, pp. 15-19. https://doi.org/10.1016/j.clon.2020.07.006

TY - JOUR

T1 - Optimising the Duration of Adjuvant Trastuzumab in Early Breast Cancer in the UK

AU - Earl, H M

AU - Hiller, L

AU - Dunn, J

AU - Macpherson, I

AU - Rea, D

AU - Hughes-Davies, L

AU - McAdam, K

AU - Hall, P

AU - Mansi, J

AU - Wheatley, D

AU - Abraham, J E

AU - Caldas, C

AU - Gasson, S

AU - O'Riordan, E

AU - Wilcox, M

AU - Miles, D

AU - Cameron, D A

AU - Wardley, A

PY - 2020/7/25

Y1 - 2020/7/25

UR - http://www.scopus.com/inward/record.url?scp=85088800392&partnerID=8YFLogxK

U2 - 10.1016/j.clon.2020.07.006

DO - 10.1016/j.clon.2020.07.006

M3 - Article

C2 - 32723485

SN - 0936-6555

VL - 33

SP - 15

EP - 19

JO - Clinical Oncology

JF - Clinical Oncology

IS - 1

ER -